Factors Associated With High Mortality of Gastric Adenocarcinoma in Thailand Versus Japan
NCT03059732 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2019-02-27
Summary
The differences in patient's clinicopathological characteristic between high and low prevalence of gastric cancer region should be further examined to elucidate factors that associate with poor survival rate of patients with gastric cancer. Therefore, this study aimed to evaluate characteristics of patients with gastric adenocarcinoma and factors associated with different outcome in Thailand and Japan to find a clue to improve patients' survival in low prevalence country such as Thailand.
This is a retrospective cohort study. It was conducted at King Chulalongkorn Memorial Hospital, Thailand and Osaka Medical Center for Cancer and Cardiovascular Disease, Japan. Eligible cases were selected by using standardized search protocols: formal computer searches of all patients seen at out-patient clinic and/or hospitalized for gastric cancer between 2010 and 2014.Two physicians, who were informed the definition of each variable, individually reviewed chart of patients.
Conditions
- Risk Factor
Interventions
- OTHER
-
Treatment
Observe the treatments of gastric cancer in each group
Sponsors & Collaborators
-
Osaka Medical Center for Cancer and Cardiovascular Diseases
collaborator OTHER -
King Chulalongkorn Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-01
- Primary Completion
- 2017-02-28
- Completion
- 2017-08-31
Countries
- Thailand
Study Locations
More Related Trials
-
Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers
NCT03468712 ·Status: UNKNOWN ·Phase: NA
-
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study
NCT03978481 ·Status: COMPLETED
-
Transcriptomic Signatures in Gastric Adenocarcinoma
NCT05319392 ·Status: UNKNOWN
-
Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma
NCT03814759 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer
NCT06673472 ·Status: COMPLETED
-
Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
NCT03425058 ·Status: COMPLETED
-
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)
NCT05361161 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
NCT01053390 ·Status: COMPLETED ·Phase: PHASE3
-
Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
NCT03632746 ·Status: UNKNOWN
-
The Possible Range of No.12a Lymph Node Dissection of Locally Advanced Gastric Cancer
NCT06033482 ·Status: UNKNOWN
-
Genomic and Dietary Aspects in Gastric Cancer Risk
NCT05934058 ·Status: NOT_YET_RECRUITING
-
Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer
NCT04850716 ·Status: UNKNOWN
-
Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)
NCT00147147 ·Status: COMPLETED ·Phase: PHASE3
-
Gastric Cancer Complicated With Bleeding
NCT06522542 ·Status: NOT_YET_RECRUITING
-
Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection
NCT03817268 ·Status: RECRUITING ·Phase: PHASE3
-
A Multifactor Prediction Model for Non-curative Outcomes in Mixed-type Early Gastric Cancer
NCT07096947 ·Status: COMPLETED
-
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
NCT06277453 ·Status: ACTIVE_NOT_RECRUITING
-
Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study
NCT06472063 ·Status: RECRUITING
-
Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer
NCT05230771 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric Cancer
NCT02179463 ·Status: UNKNOWN
-
Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer
NCT01544413 ·Status: COMPLETED ·Phase: NA
-
A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
NCT04843215 ·Status: RECRUITING ·Phase: NA
-
Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study
NCT01558011 ·Status: TERMINATED ·Phase: PHASE2
-
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
NCT02845986 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
NCT00149201 ·Status: COMPLETED ·Phase: PHASE3